Induced pluripotent stem cell derived cardiomyocytes: a new therapy for 'no-option' end stage heart failure (MRFF Stem Cell Therapies grant from University of Sydney). (2021-2026)
Experts
Professor
Peter Gray
Professorial Research Fellow
Australian Institute for Bioengineering and Nanotechnology